<i>Prevotella</i> ‐Derived Butyrate Inhibits <scp>CD8</scp> <sup>+</sup> T‐Cell Glycolysis via <scp>AKT</scp> / <scp>mTOR</scp> Signalling to Alleviate <scp>MASH</scp>
Prevotella mitigates MASH by downregulating the PI3K/AKT/mTOR-glycolysis axis in CD8<sup>+</sup> T cells via butyrate-dependent mechanisms, highlighting its potential as a microbial therapeutic candidate for MASH.
Publication Details
- Journal
- Liver International
- Published
- 2026-03-24
- DOI
- https://doi.org/10.1111/liv.70613
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00